IL-33/ST2 signaling promotes intrahepatic cholangiocarcinoma through reprogramming macrophage polarization via MAPK pathway

IL-33/ST2 signaling drives ICC progression by promoting M2 macrophage polarization via the MAPK pathway. Targeting this axis may represent a novel therapeutic strategy for ICC.

Authors

Institutions

Publication Details

Journal
Experimental Cell Research
Published
2025-12-02
DOI
https://doi.org/10.1016/j.yexcr.2025.114845
Primary Topic
IL-33, ST2, and ILC Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IL-33/ST2 signaling promotes intrahepatic cholangiocarcinoma through reprogramming macrophage polarization via MAPK pathway

Guohua Zuo, Jun Feng, Aimaiti Yasen, Xiaomin Yang et al.
Experimental Cell Research
IL-33, ST2, and ILC Pathways
article

IL-33/ST2 signaling promotes intrahepatic cholangiocarcinoma through reprogramming macrophage polarization via MAPK pathway

Guohua Zuo, Jun Feng, Aimaiti Yasen, Xiaomin Yang, Guoying Wang, Lu Zheng, Yichen Tang
article en

Abstract

IL-33/ST2 signaling drives ICC progression by promoting M2 macrophage polarization via the MAPK pathway. Targeting this axis may represent a novel therapeutic strategy for ICC.

Experimental Cell ResearchVol. 455(1)
Army Medical University (CN), First Affiliated Hospital of Guangzhou Medical University (CN), Xinqiao Hospital (CN), Guangzhou Medical University (CN)
Openalex Percentile: Top 57%
IL-33, ST2, and ILC Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.